Literature DB >> 23867220

Biomechanical properties of bone treated by magnetic resonance-guided focused ultrasound - an in vivo porcine model study.

Amir Herman1, Eran Avivi, Tamar Brosh, Ignat Schwartz, Boaz Liberman.   

Abstract

The magnetic resonance-guided focused ultrasound (MRgFUS) system uses MR imaging for real-time aiming of thermal ablation of bone and soft tissue tumors. Past clinical studies showed no increase in fracture rate after MRgFUS treatment. The purpose of this study was to determine the effect of MRgFUS treatment on mechanical properties of bone and correlate the effect to histological findings of treated bone. Four fully grown mini-pigs were treated by MRgFUS. Six consecutive right normal ribs were treated in each animal, and the left corresponding ribs served as controls. The animals were sacrificed at pre-set intervals (0, 2, 6 and 12weeks after treatment), and the treated and control bones were extracted. Mechanical properties of each bone were examined using three points bending studies for comparing treated bones to the corresponding controls. Histologic properties using Masson and hematoxylin-eosin stains were also compared. The ratio between treated and control biomechanical properties showed reduction in bone biomechanical properties at 6weeks post-MRgFUS treatment. The mean±SD yield load ratio and maximum ratios were 0.69±0.11 and 0.71±0.13, respectively (both p=0.031). These findings showed some recovery trend at 12weeks after treatment. Histological analysis showed a reduction in mean osteon size at 2weeks after treatment (0.58×10(-3)±0.1×10(-3)mm and 0.16×10(-3)±0.017×10(-3)mm) in control vs. treated bones, respectively (p=0.005). Treatment with the MRgFUS system resulted in a ~30% reduction in mechanical strength at 6weeks post-treatment. The reduction showed a reversible trend, with a 25%-20% decrease in strength at 12weeks post-treatment.
© 2013.

Entities:  

Keywords:  Biomechanics; Bone mechanical properties; MRgFUS

Mesh:

Year:  2013        PMID: 23867220     DOI: 10.1016/j.bone.2013.06.032

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  6 in total

Review 1.  MRI-guided focused ultrasound surgery in musculoskeletal diseases: the hot topics.

Authors:  Alberto Bazzocchi; Alessandro Napoli; Beatrice Sacconi; Giuseppe Battista; Giuseppe Guglielmi; Carlo Catalano; Ugo Albisinni
Journal:  Br J Radiol       Date:  2015-11-26       Impact factor: 3.039

2.  Evaluation of Quality of Life Outcomes Following Palliative Treatment of Bone Metastases with Magnetic Resonance-guided High Intensity Focused Ultrasound: An International Multicentre Study.

Authors:  D Harding; S L Giles; M R D Brown; G R Ter Haar; M van den Bosch; L W Bartels; Y-S Kim; M Deppe; N M deSouza
Journal:  Clin Oncol (R Coll Radiol)       Date:  2018-01-06       Impact factor: 4.126

3.  In vivo measurements of medial branch nerve depth and adjacent osseous structures for ablation of facet-related back pain: Predictors for patient candidacy.

Authors:  Hannah Zwiebel; Ron Aginsky; Arik Hananel; Daniel Baldor; Michael Gofeld; Jean-Francois Aubry; Suzanne D LeBlang
Journal:  N Am Spine Soc J       Date:  2020-08-07

4.  Effects of magnetic resonance-guided high-intensity focused ultrasound ablation on bone mechanical properties and modeling.

Authors:  Sin Yuin Yeo; Andrés J Arias Moreno; Bert van Rietbergen; Natalie D Ter Hoeve; Paul J van Diest; Holger Grüll
Journal:  J Ther Ultrasound       Date:  2015-08-11

Review 5.  Establishing a clinical service for the treatment of osteoid osteoma using magnetic resonance-guided focused ultrasound: overview and guidelines.

Authors:  Michael J Temple; Adam C Waspe; Joao G Amaral; Alessandro Napoli; Suzanne LeBlang; Pejman Ghanouni; Matthew D Bucknor; Fiona Campbell; James M Drake
Journal:  J Ther Ultrasound       Date:  2016-05-20

6.  Mild hyperthermia by MR-guided focused ultrasound in an ex vivo model of osteolytic bone tumour: optimization of the spatio-temporal control of the delivered temperature.

Authors:  Pauline C Guillemin; Laura Gui; Orane Lorton; Thomas Zilli; Lindsey A Crowe; Stéphane Desgranges; Xavier Montet; Sylvain Terraz; Raymond Miralbell; Rares Salomir; Sana Boudabbous
Journal:  J Transl Med       Date:  2019-10-24       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.